The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: 0.00 (0.00%)
Spread: 1.40 (4.375%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 32.70
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Peter Dines appointed as Investment Director

10 Feb 2015 07:00

RNS Number : 4619E
Mercia Technologies PLC
10 February 2015
 



RNS Reach

10 February 2015

 

Mercia Technologies PLC

 

Peter Dines appointed as Investment Director; Life Sciences

 

Mercia Technologies PLC (AIM: MERC, "Mercia" or the "Group"), a Midlands based leader in the funding and commercialisation of technology businesses in the UK, has appointed Peter Dines as Investment Director (Life Sciences).

 

Based in the Midlands and a highly successful entrepreneur and investor, Peter brings 20 years' experience in the healthcare sector, holding directorships across a wide range of life sciences businesses.

 

Peter has been involved with a number of high profile, successful investments and exits within the sector including Surgi-C where, as Managing Director, sales quadrupled within three years and the business was subsequently sold to Living Bridge (formerly ISIS Equity Partners).

 

Other key healthcare positions held, both previously and currently, include Bridges Ventures, Cisiv, Diagnostic World, Spring Active and Newtech Ortho.

 

Mark Payton, CEO of Mercia Technologies PLC, said:

 

"We are delighted to welcome Peter to Mercia. Peter is highly regarded for his track record in sourcing and rapidly growing value through hands-on management in businesses within the medtech and life sciences sector.

 

"Peter joins the three other sector-specific investment directors who lead our investment activity across Digital; Electronics and Hardware; and Advanced Materials, Engineering and Specialised Manufacturing.

 

"His remit across the Life Sciences sector will be specifically on medtech, contract services and diagnostics."

 

Enquiries:

 

Mercia Technologies PLC (www.merciatechnologies.com)

+44 (0) 330 223 1430

Mark Payton, CEO

Cenkos Securities

+44 (0) 20 7397 8900

Ivonne Cantu / Michael Johnson

Instinctif Partners

+44 (0) 20 7457 2020

Adrian Duffield / Kay Larsen

 

Note to editors

 

Mercia Technologies PLC

Mercia creates, funds and develops technology businesses nationally with an emphasis in the Midlands and the North of the UK. It brings technology transfer, company formation, incubation, commercialisation and investment, to technology ventures.

 

Mercia has a well seeded portfolio and pipeline of investments. The Group has a direct investment in 12 operating companies and access to a portfolio of 38 businesses through its third party funds, managed by its wholly owned subsidiary Mercia Fund Management.

 

Mercia's shares started trading on AIM on 18 December 2014.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASSUFWUFISEFE
Date   Source Headline
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited
19th Oct 20167:00 amRNSWarwick Audio Technologies strengthens Board

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.